Xavier Castellsagué

Active 1992–2022

119
Papers
45,833
Citations
95
h-index
119
i10-index

Citations

Citations per year for Xavier Castellsagué1992: 3 citations1993: 4 citations1994: 2 citations1995: 7 citations1996: 10 citations1997: 14 citations1998: 14 citations1999: 11 citations2000: 19 citations2001: 12 citations2002: 50 citations2003: 83 citations2004: 83 citations2005: 153 citations2006: 191 citations2007: 227 citations2008: 287 citations2009: 286 citations2010: 317 citations2011: 381 citations2012: 404 citations2013: 393 citations2014: 343 citations2015: 463 citations2016: 328 citations2017: 430 citations2018: 345 citations2019: 1,318 citations2020: 1,197 citations2021: 1,075 citations2022: 763 citations2023: 550 citations2024: 751 citations2025: 326 citations2026: 8 citations

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,859 citing papers, 20% of this breakdownChina: 982 citing papers, 6.9% of this breakdownUnited Kingdom: 945 citing papers, 6.6% of this breakdownFrance: 684 citing papers, 4.8% of this breakdownGermany: 564 citing papers, 3.9% of this breakdownItaly: 557 citing papers, 3.9% of this breakdownCanada: 509 citing papers, 3.5% of this breakdownSpain: 502 citing papers, 3.5% of this breakdownNetherlands: 495 citing papers, 3.5% of this breakdownAustralia: 426 citing papers, 3% of this breakdownIndia: 332 citing papers, 2.3% of this breakdownBrazil: 317 citing papers, 2.2% of this breakdown
0%20%Other 35.9%

Fields

  • Medicine74.9%
  • Biochemistry, Genetics and Molecular Biology13.2%
  • Immunology and Microbiology4.3%
  • Dentistry1.5%
  • Health Professions1.2%
  • Social Sciences0.7%
  • Other4.2%

Topics

  • Cervical Cancer and HPV Research17.2%
  • Head and Neck Cancer Studies7.8%
  • Genital Health and Disease4.1%
  • Hepatitis B Virus Studies3.4%
  • Reproductive tract infections research3.3%
  • Endometrial and Cervical Cancer Treatments3%
  • Other61.2%

Coauthors

All papers

Open in search
  1. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clara Menéndez, Efrén Javier Domingo, Julio Velasco, Ashrafun Nessa, Saibua C Bunnag Chichareon, You‐Lin Qiao, Enrique Lerma, Suzanne M. Garland, Toshiyuki Sasagawa, Annabelle Ferrera, Doudja Hammouda, Luciano Mariani, Adela Pelayo, I Steiner, Esther Oliva, Chris J.L.M. Meijer, Waleed Al-Jassar, Eugénia Cruz, Thomas C. Wright, A Puras, Cecilia Llave, Maria Tzardi, Θεόδωρος Αγοραστός, Victoria García-Barriola, Christine Clavel, Jaume Ordï, Miguel Andújar, Xavier Castellsagué, Gloria Inés Sánchez, Andrzej Nowakowski, Jacob Bornstein, Nubia Muñóz, F. Xavier Bosch - The Lancet Oncology 2010 cited by 2,728

  2. Epidemiologic Classification of Human Papillomavirus Types Associated with Cervical Cancer

    Authors: , , , , , , , - New England Journal of Medicine 2003 cited by 6,297

  3. Cervical Human Papillomavirus Prevalence in 5 Continents: Meta‐Analysis of 1 Million Women with Normal Cytological Findings

    Authors: , , , , , - The Journal of Infectious Diseases 2010 cited by 1,630

  4. Global estimates of human papillomavirus vaccination coverage by region and income level: a pooled analysis

    Authors: , , , , , , , - The Lancet Global Health 2016 cited by 827

  5. Worldwide prevalence and genotype distribution of cervical human papillomavirus DNA in women with normal cytology: a meta-analysis

    Authors: , , , , , , - The Lancet Infectious Diseases 2007 cited by 1,669

  6. Skin Cancer: Epidemiology, Disease Burden, Pathophysiology, Diagnosis, and Therapeutic Approaches

    Authors: , , , - Dermatology and Therapy 2017 cited by 461

  7. Interaction between Tobacco and Alcohol Use and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Stephen M. Schwartz, Elaine Smith, Erich M. Sturgis, Neonilia Szeszenia‐Dabrowska, Renato Talamini, Qingyi Wei, Deborah M. Winn, Oxana Shangina, Agnieszka Pilarska, Zuo‐Feng Zhang, Gilles Ferro, Julien Berthiller, Paolo Boffetta - Cancer Epidemiology Biomarkers & Prevention 2009 cited by 1,244

  8. A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines

    Authors: , , - Vaccine 2012 cited by 742

  9. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis

    Authors: , , , , , , , , - The Lancet Oncology 2014 cited by 729

  10. HPV Involvement in Head and Neck Cancers: Comprehensive Assessment of Biomarkers in 3680 Patients

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Oluseyi F. Ajayi, Flora Duarte, Ashrafun Nessa, Leopoldo Tinoco, Marco A. Durán-Padilla, Edyta C. Pirog, Halina Viarheichyk, Hesler Morales, Valérie Costes, Ana Félix, Maria Julieta V. Germar, M. Mena, Arzu Ruacan, Asha Jain, Ravi Mehrotra, Marc T. Goodman, Luis Estuardo Lombardi, Annabelle Ferrera, Sani Malami, Estela I. Albanesi, Pablo Dabed, Carla Molina, Rubén López‐Revilla, Václav Mandys, Manuel González, Julio Velasco, Ignacio G. Bravo, Wim Quint, Michael Pawlita, Núbia Muñóz, Silvia de Sanjosé, F. Xavier Bosch - JNCI Journal of the National Cancer Institute 2016 cited by 752

  11. Alcohol Drinking in Never Users of Tobacco, Cigarette Smoking in Never Drinkers, and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , D. M. Winn, Давид Заридзе, Witold Zatoński, Zuo‐Feng Zhang, J. Berthiller, P. Boffetta - JNCI Journal of the National Cancer Institute 2007 cited by 1,110

  12. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2009 cited by 1,655

  13. Natural history and epidemiology of HPV infection and cervical cancer

    Authors: - Gynecologic Oncology 2008 cited by 594

  14. Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2011 cited by 703

  15. Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard B. Hayes, Silvia Franceschi, Victor Wünsch-Filho, Leticia Fernandez, Eleonora Fabianova, Alexander W. Daudt, Luigino Dal Maso, María Paula Curado, Chu Chen, Xavier Castellsagué, Marcos Brasilino de Carvalho, Gabriella Cadoni, Stefania Boccia, Paul Brennan, Paolo Boffetta, A.F. Olshan - American Journal of Epidemiology 2013 cited by 302

  16. Chapter 1: HPV in the etiology of human cancer

    Authors: , , , - Vaccine 2006 cited by 1,368

  17. Comprehensive Control of Human Papillomavirus Infections and Related Diseases

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Vaccine 2013 cited by 440

  18. Role of Human Papillomavirus in Penile Carcinomas Worldwide

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jose D. Mota, Robert Jach, Julio Velasco, Carla Carrilho, Rubén López‐Revilla, Marc T. Goodman, Wim Quint, Xavier Castellsagué, Ignacio G. Bravo, Michael Pawlita, Nubia Muñóz, F. Xavier Bosch, Silvia de Sanjosé - European Urology 2016 cited by 293

  19. Worldwide burden of cervical cancer in 2008

    Authors: , , , , , , - Annals of Oncology 2011 cited by 1,147

  20. Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2011 cited by 507

  21. Smoking as a major risk factor for cervical cancer and pre-cancer: Results from the EPIC cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Petra H. Peeters, Eiliv Lund, Elisabete Weiderpass, María Luisa Redondo, María‐José Sánchez, María-José Tormo, Aurelio Barricarte, Nerea Larrañaga, Johanna Ekström, Maria Hortlund, David Lindquist, Nick Wareham, Ruth C. Travis, Sabina Rinaldi, Massimo Tommasino, Silvia Franceschi, Elio Ríboli - International Journal of Cancer 2013 cited by 291

  22. The Influence of Hormonal Factors on the Risk of Developing Cervical Cancer and Pre-Cancer: Results from the EPIC Cohort

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Eiliv Lund, Petra H. Peeters, H. B. Bueno-de-Mesquita, J. Ramón Quirós, María‐José Sánchez, Carmen Navarro, Aurelio Barricarte, Nerea Larrañaga, Johanna Ekström, David Lindquist, Annika Idahl, Ruth C. Travis, Melissa A. Merritt, Marc J. Gunter, Sabina Rinaldi, Massimo Tommasino, Silvia Franceschi, Elio Ríboli, Xavier Castellsagué - PLoS ONE 2016 cited by 209

  23. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - The Lancet 2007 cited by 1,315

  24. End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24–45 years of age

    Authors: , , , , , , , , , , , , , - British Journal of Cancer 2011 cited by 346